| __timestamp | Amgen Inc. | Dynavax Technologies Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 4699000000 | 17763000 |
| Thursday, January 1, 2015 | 4846000000 | 22180000 |
| Friday, January 1, 2016 | 5062000000 | 37257000 |
| Sunday, January 1, 2017 | 4870000000 | 27367000 |
| Monday, January 1, 2018 | 5332000000 | 64770000 |
| Tuesday, January 1, 2019 | 5150000000 | 74986000 |
| Wednesday, January 1, 2020 | 5730000000 | 79256000 |
| Friday, January 1, 2021 | 5368000000 | 100156000 |
| Saturday, January 1, 2022 | 5414000000 | 131408000 |
| Sunday, January 1, 2023 | 6179000000 | 152946000 |
| Monday, January 1, 2024 | 7096000000 |
Unleashing insights
In the ever-evolving world of biotechnology, understanding the financial dynamics of industry leaders is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Amgen Inc. and Dynavax Technologies Corporation from 2014 to 2023. Over this period, Amgen's SG&A costs have consistently dwarfed those of Dynavax, reflecting its expansive operations and market reach. In 2023, Amgen's expenses surged to nearly 6.2 billion, marking a 31% increase from 2014. In contrast, Dynavax, a smaller player, saw its SG&A expenses grow by an impressive 760%, reaching approximately 153 million in 2023. This stark contrast highlights the differing scales and growth trajectories of these companies. As the biotech sector continues to innovate, monitoring such financial metrics offers valuable insights into corporate strategies and market positioning.
Operational Costs Compared: SG&A Analysis of Johnson & Johnson and Amgen Inc.
Who Optimizes SG&A Costs Better? Amgen Inc. or Walgreens Boots Alliance, Inc.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Exelixis, Inc.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Cytokinetics, Incorporated
Comparing SG&A Expenses: Amgen Inc. vs TG Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Amgen Inc. vs Viking Therapeutics, Inc.
Breaking Down SG&A Expenses: Amgen Inc. vs Merus N.V.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Soleno Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Amgen Inc. and Agios Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Blueprint Medicines Corporation and Dynavax Technologies Corporation
Madrigal Pharmaceuticals, Inc. and Dynavax Technologies Corporation: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Vericel Corporation vs Dynavax Technologies Corporation